Last reviewed · How we verify
NCT04547465
2D Speckle-tracking Echocardiography in Chemotherapy-induced Cardiomyopathy With Cardiovascular Risk Factors
trial testing Echocardiography in Cardiomyopathy Due to Drug in 300 participants. Status unknown.
30 October 2023
Quick facts
| Lead sponsor | Gia Dinh People Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 15 September 2020 |
| Primary completion | 30 October 2023 |
| Estimated completion | 30 December 2023 |
| Sites | 1 location across Vietnam |
Drugs / interventions tested
- Echocardiography
Conditions studied
- Cardiomyopathy Due to Drug — all drugs for Cardiomyopathy Due to Drug →
- Breast Cancer — all drugs for Breast Cancer →
- Cardiovascular Risk Factor — all drugs for Cardiovascular Risk Factor →
Sponsor
Gia Dinh People Hospital
Who can join
18 and older, any sex, with Cardiomyopathy Due to Drug or Breast Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aims of this study is to evaluate the role of 2D speckle-tracking echocardiography in diagnosis chemotherapy related left ventricular dysfunction in breast cancer patients with cardiovascular risks
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Features of trastuzumab-related cardiac dysfunction: deformation analysis outside left ventricular global longitudinal strain.
Nhat GM, Hai NH, Duc VT, Tri HHQ, et al · · 2024 · cited 6× · PMID 38312233 · DOI 10.3389/fcvm.2024.1291180
Verify or expand the search:
- PubMed search for NCT04547465
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Echocardiography
Trials testing the same drug.
- NCT06863402 — Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype · Phase 2 · recruiting
- NCT07372859 — Women's Heart: Impact of Ultra-endurance and Hormonal Profile on Cardiac and Systemic Inflammatory Parameters in Female · NA · not yet recruiting
- NCT06434064 — Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advan · Phase 2 · recruiting
- NCT06871410 — Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia · Phase 1 · recruiting
- NCT07375433 — Heart Failure With Preserved Ejection Fraction in Patients With Сhronic Obstructive Pulmonary Disease: Clinical Course a · recruiting
Other recruiting trials for Cardiomyopathy Due to Drug
Currently open trials in the same condition.
- NCT06309862 — Immune Checkpoint Inhibitor Therapy for Cancer and Risk of Myocarditis or Cardiomyopathy · recruiting
Other Gia Dinh People Hospital trials
Trials by the same sponsor.
- NCT07234929 — Effectiveness of Chat-based Mobile Application for Consultation (Zalo) in Improving Compliance With Follow-up Tests Afte · NA · not yet recruiting
- NCT06486233 — Studying the Effectiveness of Early Invasive Treatment in Elderly Patients With High-risk Non-ST-segment Elevation Acute · recruiting
- NCT07237841 — Preoperative Carbohydrate Loading in Diabetes Mellitus · NA · completed
- NCT04331132 — Tolvaptan add-on Therapy to Overcome Loop Diuretic Resistance in Acute Heart Failure With Renal Dysfunction · NA · unknown
- NCT04491786 — The Efficacy of Postoperative Analgesia of Gabapentin Plus Nefopam in the Spinal Surgery · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04547465 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gia Dinh People Hospital
- Last refreshed: 8 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04547465.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing